[go: up one dir, main page]

MX378376B - Composicion farmaceutica para el tratamiento de la micosis. - Google Patents

Composicion farmaceutica para el tratamiento de la micosis.

Info

Publication number
MX378376B
MX378376B MX2017008879A MX2017008879A MX378376B MX 378376 B MX378376 B MX 378376B MX 2017008879 A MX2017008879 A MX 2017008879A MX 2017008879 A MX2017008879 A MX 2017008879A MX 378376 B MX378376 B MX 378376B
Authority
MX
Mexico
Prior art keywords
mycosis
treatment
pharmaceutical composition
combination
benzydamine
Prior art date
Application number
MX2017008879A
Other languages
English (en)
Other versions
MX2017008879A (es
Inventor
De Joannon Alessandra Capezzone
Claudio Milanese
Luca Donati
Serena Tongiani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MX2017008879A publication Critical patent/MX2017008879A/es
Publication of MX378376B publication Critical patent/MX378376B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se relaciona a una composición farmacéutica que comprende una combinación de bencidamina y un ingrediente activo antimicótico, donde dicha combinación tiene un efecto sinérgico en el tratamiento de micosis.
MX2017008879A 2015-01-13 2016-01-08 Composicion farmaceutica para el tratamiento de la micosis. MX378376B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150904 2015-01-13
PCT/EP2016/050272 WO2016113194A1 (en) 2015-01-13 2016-01-08 Pharmaceutical composition for the treatment of mycosis

Publications (2)

Publication Number Publication Date
MX2017008879A MX2017008879A (es) 2018-03-28
MX378376B true MX378376B (es) 2025-03-10

Family

ID=52396443

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008879A MX378376B (es) 2015-01-13 2016-01-08 Composicion farmaceutica para el tratamiento de la micosis.

Country Status (30)

Country Link
US (1) US9962372B2 (es)
EP (1) EP3244889B1 (es)
JP (1) JP6714597B2 (es)
KR (1) KR102606081B1 (es)
CN (1) CN107106690B (es)
AR (1) AR103381A1 (es)
AU (1) AU2016208200B2 (es)
BR (1) BR112017014295B1 (es)
CA (1) CA2970060C (es)
CY (1) CY1122979T1 (es)
DK (1) DK3244889T3 (es)
EA (1) EA035748B1 (es)
ES (1) ES2794824T3 (es)
GE (1) GEP20196962B (es)
HK (1) HK1246146A1 (es)
HR (1) HRP20200815T1 (es)
HU (1) HUE049877T2 (es)
IL (1) IL252774A0 (es)
LT (1) LT3244889T (es)
MD (1) MD3244889T2 (es)
ME (1) ME03736B (es)
MX (1) MX378376B (es)
PL (1) PL3244889T3 (es)
PT (1) PT3244889T (es)
RS (1) RS60508B1 (es)
SG (1) SG11201704964RA (es)
SI (1) SI3244889T1 (es)
SM (1) SMT202000277T1 (es)
UA (1) UA120864C2 (es)
WO (1) WO2016113194A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2877133T3 (es) 2016-07-08 2021-11-16 Acraf Composición farmacéutica que comprende bencidamina
CN112514904B (zh) * 2021-01-26 2021-10-26 青岛农业大学 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
IT1274655B (it) * 1995-02-28 1997-07-18 Smithkline Beecham Farma Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
PT2018164T (pt) * 2006-05-12 2017-06-12 Christian Noe Utilização de preparações combinadas que compreendem antimicóticos
CN1887352A (zh) * 2006-07-13 2007-01-03 徐艳 治疗眼部真菌和细菌感染的组合物
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination

Also Published As

Publication number Publication date
SI3244889T1 (sl) 2020-08-31
MD3244889T2 (ro) 2020-06-30
CA2970060C (en) 2023-10-03
US20180000783A1 (en) 2018-01-04
RS60508B1 (sr) 2020-08-31
EP3244889A1 (en) 2017-11-22
CY1122979T1 (el) 2021-10-29
WO2016113194A1 (en) 2016-07-21
ME03736B (me) 2021-01-20
AR103381A1 (es) 2017-05-03
UA120864C2 (uk) 2020-02-25
JP6714597B2 (ja) 2020-06-24
BR112017014295B1 (pt) 2023-04-25
MX2017008879A (es) 2018-03-28
CN107106690A (zh) 2017-08-29
EA201791483A1 (ru) 2017-11-30
HK1246146A1 (zh) 2018-09-07
PT3244889T (pt) 2020-06-04
DK3244889T3 (da) 2020-06-02
CN107106690B (zh) 2020-11-10
JP2018501277A (ja) 2018-01-18
AU2016208200B2 (en) 2020-09-03
KR20170101941A (ko) 2017-09-06
EP3244889B1 (en) 2020-03-04
US9962372B2 (en) 2018-05-08
PL3244889T3 (pl) 2020-11-02
GEP20196962B (en) 2019-04-10
HUE049877T2 (hu) 2020-10-28
EA035748B1 (ru) 2020-08-05
BR112017014295A2 (pt) 2018-03-06
SG11201704964RA (en) 2017-07-28
CA2970060A1 (en) 2016-07-21
SMT202000277T1 (it) 2020-09-10
HRP20200815T1 (hr) 2020-08-07
KR102606081B1 (ko) 2023-11-24
LT3244889T (lt) 2020-08-10
IL252774A0 (en) 2017-08-31
ES2794824T3 (es) 2020-11-19
AU2016208200A1 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
MX382339B (es) Inhibidores g12c de kras.
MX2018003388A (es) Agonistas del receptor farnesoide x y usos de los mismos.
MX378273B (es) Compuestos activos hacia bromodominios.
MX2018006240A (es) Composiciones que comprenden cepas bacterianas.
NI201600071A (es) Compuestos de inhibidor de autotaxina
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
IL261982A (en) A prophylactic and therapeutic preparation based on peroxaphthalate, especially a pharmaceutical preparation
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
RS59758B1 (sr) Kv1.3 inhibitori i njihova medicinska primena
CL2018003338A1 (es) Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant.
MX381792B (es) Agente terapéutico para la fibrosis.
BR112017004552A2 (pt) composições farmacêuticas
CY1122979T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια της μυκητιασης
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
MX373177B (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
MX384394B (es) Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas.
MX393608B (es) Profilactico o agente terapeutico para queratitis fungica.
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
MX2016009567A (es) Composicion antifungica.
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
MX2019003366A (es) Ajuste de la dosis.
PL409699A1 (pl) Kompozycja farmaceutyczna zawierająca nystatynę oraz beta-escynę lub ich dopuszczalne farmaceutycznie sole oraz jej zastosowanie
BR112017006190A2 (pt) agentes terapêuticos humanos